{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:57:48Z","timestamp":1792799868587,"version":"4.5.0"},"reference-count":217,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":114,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RO1 AG054046"],"award-info":[{"award-number":["RO1 AG054046"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1 AG054991"],"award-info":[{"award-number":["RF1 AG054991"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s13311-023-01370-8","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T10:02:51Z","timestamp":1687946571000},"page":"955-974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Charting the Next Road Map for CSF Biomarkers in Alzheimer's Disease and Related Dementias"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4862-6777","authenticated-orcid":false,"given":"William T.","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashima","family":"Nayyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milota","family":"Kaluzova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0006-291X(87)91312-X","article-title":"High molecular weight Alzheimer's disease amyloid peptide immunoreactivity in human serum and CSF is an immunoglobulin G","volume":"145","author":"Pardridge","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3174\/ajnr.A6870","article-title":"National trends in lumbar puncture from 2010 to 2018: a shift reversal from the emergency department to the hospital setting for radiologists and advanced practice providers","volume":"42","author":"Trunz","year":"2021","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1007\/s13311-023-01370-8_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1471-4159.1960.tb13448.x","article-title":"The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF gamma-globulins","volume":"6","author":"Lowenthal","year":"1960","journal-title":"J Neurochem"},{"issue":"4","key":"10.1007\/s13311-023-01370-8_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S0317167100022733","article-title":"CSF electrophoresis in one thousand patients","volume":"7","author":"Ebers","year":"1980","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/clinchem\/36.1.123","article-title":"Oligoclonal bands in cerebrospinal fluid detected by PhastSystem isoelectric focusing","volume":"36","author":"Wybo","year":"1990","journal-title":"Clin Chem"},{"issue":"4","key":"10.1007\/s13311-023-01370-8_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s10875-005-5371-9","article-title":"Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry","volume":"25","author":"Desplat-Jego","year":"2005","journal-title":"J Clin Immunol"},{"key":"10.1007\/s13311-023-01370-8_bib8","first-page":"744","article-title":"Semi-automated image analysis of gel electrophoresis of cerebrospinal fluid for oligoclonal band detection","volume":"2016","author":"Boudet","year":"2016","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"10.1007\/s13311-023-01370-8_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.clinbiochem.2018.04.005","article-title":"Evaluation of Cobas 8000(R) for the quantification of albumin and IgG in serum and cerebrospinal fluid","volume":"56","author":"Puissant-Lubrano","year":"2018","journal-title":"Clin Biochem"},{"issue":"22","key":"10.1007\/s13311-023-01370-8_bib10","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"issue":"31","key":"10.1007\/s13311-023-01370-8_bib11","first-page":"2465","article-title":"Establishment and consistency verification of the standard operation procedure for laboratory detection of immunoglobulin G oligoclonal bands in cerebrospinal fluid","volume":"101","author":"Liu","year":"2021","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"10","key":"10.1007\/s13311-023-01370-8_bib12","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1212\/WNL.0000000000001335","article-title":"Residency training: a failed lumbar puncture is more about obesity than lack of ability","volume":"84","author":"Edwards","year":"2015","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01370-8_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/651058","article-title":"Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells","volume":"2012","author":"Voigt","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/cyto.a.21009","article-title":"Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay","volume":"79","author":"Grossmann","year":"2011","journal-title":"Cytometry A"},{"issue":"10","key":"10.1007\/s13311-023-01370-8_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.autrev.2011.12.010","article-title":"A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence","volume":"11","author":"Melegari","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10067-011-1884-1","article-title":"A novel automated indirect immunofluorescence autoantibody evaluation","volume":"31","author":"Kivity","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1007\/s13311-023-01370-8_bib17","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1515\/cclm-2013-0016","article-title":"Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation","volume":"51","author":"Bonroy","year":"2013","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"Agmon-Levin","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.autrev.2013.10.015","article-title":"Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems","volume":"13","author":"Bizzaro","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1007\/s13311-023-01370-8_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cca.2015.12.034","article-title":"ICARE improves antinuclear antibody detection by overcoming the barriers preventing accreditation","volume":"454","author":"Bertin","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1007\/s13311-023-01370-8_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6038137","article-title":"ANA IIF automation: moving towards harmonization? Results of a multicenter study","volume":"2017","author":"Van den Bremt","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1007\/s13311-023-01370-8_bib22","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3389\/fimmu.2018.00927","article-title":"Automated processing and evaluation of anti-nuclear antibody indirect immunofluorescence testing","volume":"9","author":"Ricchiuti","year":"2018","journal-title":"Front Immunol"},{"key":"10.1007\/s13311-023-01370-8_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jim.2018.02.014","article-title":"A step towards standardization: a method for end-point titer determination by fluorescence index of an automated microscope. End-point titer determination by fluorescence index","volume":"456","author":"Carbone","year":"2018","journal-title":"J Immunol Methods"},{"issue":"7","key":"10.1007\/s13311-023-01370-8_bib24","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1515\/cclm-2018-0933","article-title":"Harmonizing by reducing inter-run variability: performance evaluation of a quality assurance program for antinuclear antibody detection by indirect immunofluorescence","volume":"57","author":"Bogaert","year":"2019","journal-title":"Clin Chem Lab Med"},{"issue":"7","key":"10.1007\/s13311-023-01370-8_bib25","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1515\/cclm-2020-1669","article-title":"Integrating quality assurance in autoimmunity: the changing face of the automated ANA IIF test","volume":"59","author":"Van Hoovels","year":"2021","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3343\/alm.2022.42.1.63","article-title":"Clinical performance of two automated immunoassays, EliA CTD screen and QUANTA flash CTD screen plus, for antinuclear antibody screening","volume":"42","author":"Yoon","year":"2022","journal-title":"Ann Lab Med"},{"issue":"8","key":"10.1007\/s13311-023-01370-8_bib27","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/01.wnl.0000180608.76190.10","article-title":"Should the Babinski sign be part of the routine neurologic examination?","volume":"65","author":"Miller","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7861\/clinmedicine.14-3-264","article-title":"Inter-rater agreement of observable and elicitable neurological signs","volume":"14","author":"Thaller","year":"2014","journal-title":"Clin Med (Lond)"},{"issue":"12","key":"10.1007\/s13311-023-01370-8_bib29","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1001\/jamainternmed.2022.4969","article-title":"Artificial intelligence in breast cancer screening: evaluation of FDA device regulation and future recommendations","volume":"182","author":"Potnis","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-010-0723-9","article-title":"Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease","volume":"120","author":"Hu","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"9","key":"10.1007\/s13311-023-01370-8_bib31","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jamaneurol.2021.2293","article-title":"Comparison of plasma phosphorylated tau species with amyloid and tau positron emission tomography, neurodegeneration, vascular pathology, and cognitive outcomes","volume":"78","author":"Mielke","year":"2021","journal-title":"JAMA Neurol"},{"issue":"23","key":"10.1007\/s13311-023-01370-8_bib32","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181c5b445","article-title":"CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease","volume":"73","author":"Clifford","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archneurol.2011.761","article-title":"11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder","volume":"69","author":"Ances","year":"2012","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-45418-2","article-title":"Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder","volume":"9","author":"Ozturk","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"10.1007\/s13311-023-01370-8_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/amiajnl-2013-002239","article-title":"Patient access to medical records and healthcare outcomes: a systematic review","volume":"21","author":"Davis Giardina","year":"2014","journal-title":"J Am Med Inform Assoc"},{"issue":"10","key":"10.1007\/s13311-023-01370-8_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.29553","article-title":"Association of immediate release of test results to patients with implications for clinical workflow","volume":"4","author":"Steitz","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","article-title":"Biomarkers: potential uses and limitations","volume":"1","author":"Mayeux","year":"2004","journal-title":"NeuroRx"},{"issue":"8","key":"10.1007\/s13311-023-01370-8_bib38","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41551-022-00935-w","article-title":"Straightforward, inexpensive and sensitive","volume":"6","author":"Ghouneimy","year":"2022","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.ajkd.2012.12.022","article-title":"Biomarkers in nephrology: core curriculum 2013","volume":"62","author":"McMahon","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66154-y","article-title":"Association between cerebrospinal fluid biomarkers and age-related brain changes in patients with normal pressure hydrocephalus","volume":"10","author":"Taghdiri","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"10.1007\/s13311-023-01370-8_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10051105","article-title":"Elevated CSF LRG and decreased Alzheimer's disease biomarkers in idiopathic normal pressure hydrocephalus","volume":"10","author":"Vanninen","year":"2021","journal-title":"J Clin Med"},{"issue":"6","key":"10.1007\/s13311-023-01370-8_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12060935","article-title":"Alzheimer's disease CSF biomarker profiles in idiopathic normal pressure hydrocephalus","volume":"12","author":"Mazzeo","year":"2022","journal-title":"J Pers Med"},{"issue":"17","key":"10.1007\/s13311-023-01370-8_bib43","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1212\/WNL.0000000000000916","article-title":"Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus","volume":"83","author":"Graff-Radford","year":"2014","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01370-8_bib44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neurobiolaging.2019.01.008","article-title":"The influence of tau, amyloid, alpha-synuclein, TDP-43, and vascular pathology in clinically normal elderly individuals","volume":"77","author":"Wennberg","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-023-01370-8_bib45","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neurobiolaging.2017.06.012","article-title":"Clinically silent Alzheimer's and vascular pathologies influence brain networks supporting executive function in healthy older adults","volume":"58","author":"Gold","year":"2017","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib46","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.neurobiolaging.2013.08.027","article-title":"Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults","volume":"35","author":"Mattsson","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"8","key":"10.1007\/s13311-023-01370-8_bib47","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1038\/tp.2013.69","article-title":"CSF protein biomarkers predicting longitudinal reduction of CSF beta-amyloid42 in cognitively healthy elders","volume":"3","author":"Mattsson","year":"2013","journal-title":"Transl Psychiatry"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ana.10086","article-title":"Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease","volume":"51","author":"Mitchell","year":"2002","journal-title":"Ann Neurol"},{"issue":"19","key":"10.1007\/s13311-023-01370-8_bib49","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1212\/WNL.0000000000004609","article-title":"Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls","volume":"89","author":"Mollenhauer","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib50","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1007\/s13311-023-01370-8_bib51","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1007\/s13311-023-01370-8_bib52","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1007\/s13311-023-01370-8_bib53","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00401-010-0667-0","article-title":"Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment","volume":"119","author":"Hu","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00401-008-0400-4","article-title":"Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease","volume":"116","author":"Hu","year":"2008","journal-title":"Acta Neuropathol"},{"issue":"11","key":"10.1007\/s13311-023-01370-8_bib55","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1093\/brain\/aww224","article-title":"TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia","volume":"139","author":"James","year":"2016","journal-title":"Brain"},{"issue":"6","key":"10.1007\/s13311-023-01370-8_bib56","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/alz.12079","article-title":"Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease","volume":"16","author":"de Flores","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00401-010-0698-6","article-title":"FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration","volume":"120","author":"Urwin","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-018-1878-z","article-title":"Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype","volume":"136","author":"Koga","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1007\/s13311-023-01370-8_bib60","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jprot.2010.02.004","article-title":"Characterization of the human ventricular cerebrospinal fluid proteome obtained from hydrocephalic patients","volume":"73","author":"Waybright","year":"2010","journal-title":"J Proteomics"},{"issue":"1\u20132","key":"10.1007\/s13311-023-01370-8_bib61","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(01)01514-2","article-title":"Ex vivo lumbar and post mortem ventricular cerebrospinal fluid substance P-immunoreactivity in Alzheimer's disease patients","volume":"299","author":"Rosler","year":"2001","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib62","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11064-010-0374-1","article-title":"Rostrocaudal dynamics of CSF biomarkers","volume":"36","author":"Tarnaris","year":"2011","journal-title":"Neurochem Res"},{"issue":"3\u20134","key":"10.1007\/s13311-023-01370-8_bib63","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000352032","article-title":"Neuroprotein dynamics in the cerebrospinal fluid: intraindividual concomitant ventricular and lumbar measurements","volume":"70","author":"Brandner","year":"2013","journal-title":"Eur Neurol"},{"issue":"4","key":"10.1007\/s13311-023-01370-8_bib64","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3233\/JAD-132708","article-title":"Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer's disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus","volume":"41","author":"Brandner","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12987-016-0039-9","article-title":"Small cisterno-lumbar gradient of phosphorylated tau protein in geriatric patients with suspected normal pressure hydrocephalus","volume":"13","author":"Djukic","year":"2016","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12987-021-00256-1","article-title":"Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus","volume":"18","author":"Minta","year":"2021","journal-title":"Fluids Barriers CNS"},{"issue":"9","key":"10.1007\/s13311-023-01370-8_bib67","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"issue":"383","key":"10.1007\/s13311-023-01370-8_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai7866","article-title":"Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis","volume":"9","author":"Gendron","year":"2017","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib69","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.24980","article-title":"Phosphorylated neurofilament heavy chain: a biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis","volume":"82","author":"Gendron","year":"2017","journal-title":"Ann Neurol"},{"issue":"23","key":"10.1007\/s13311-023-01370-8_bib70","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1212\/WNL.0b013e318200d78d","article-title":"Novel CSF biomarkers for frontotemporal lobar degenerations","volume":"75","author":"Hu","year":"2010","journal-title":"Neurology"},{"issue":"22","key":"10.1007\/s13311-023-01370-8_bib71","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/01.wnl.0000436625.63650.27","article-title":"Reduced CSF p-Tau181 to tau ratio is a biomarker for FTLD-TDP","volume":"81","author":"Hu","year":"2013","journal-title":"Neurology"},{"issue":"21","key":"10.1007\/s13311-023-01370-8_bib72","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1001\/jama.1984.03350210038026","article-title":"Do patients want to participate in medical decision making?","volume":"252","author":"Strull","year":"1984","journal-title":"JAMA"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib73","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.socscimed.2007.03.036","article-title":"Physicians' communication and perceptions of patients: is it how they look, how they talk, or is it just the doctor?","volume":"65","author":"Street","year":"2007","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib74","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11606-010-1453-3","article-title":"How well do doctors know their patients? Factors affecting physician understanding of patients' health beliefs","volume":"26","author":"Street","year":"2011","journal-title":"J Gen Intern Med"},{"key":"10.1007\/s13311-023-01370-8_bib75","first-page":"65","article-title":"Routine lumbar puncture for the early diagnosis of Alzheimer's disease. Is it safe?","volume":"6","author":"Menendez-Gonzalez","year":"2014","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"10.1007\/s13311-023-01370-8_bib76","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1582-4934.2008.00313.x","article-title":"Biomarkers for early diagnosis of Alzheimer disease: \u2018ALZheimer ASsociated gene'\u2013a new blood biomarker?","volume":"12","author":"Jellinger","year":"2008","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib77","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ymeth.2008.05.005","article-title":"Non-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood","volume":"46","author":"Freudenberg","year":"2008","journal-title":"Methods"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib78","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbrc.2009.05.037","article-title":"Elevation of plasma beta-amyloid level by glucose loading in Alzheimer mouse models","volume":"385","author":"Takeda","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1007\/s13311-023-01370-8_bib79","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1017\/S1461145711000459","article-title":"Identification of a blood-based biomarker panel for classification of Alzheimer's disease","volume":"14","author":"Laske","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib80","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13195-019-0535-7","article-title":"Association between increased levels of amyloid-beta oligomers in plasma and episodic memory loss in Alzheimer's disease","volume":"11","author":"Meng","year":"2019","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib81","article-title":"Novel blood test for early biomarkers of preeclampsia and Alzheimer's disease","volume":"11","author":"Cheng","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1007\/s13311-023-01370-8_bib82","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jacr.2017.01.043","article-title":"Prevalence of unanticipated events associated with MRI examinations: a benchmark for MRI quality, safety, and patient experience","volume":"14","author":"Sadigh","year":"2017","journal-title":"J Am Coll Radiol"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib83","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jalz.2015.08.003","article-title":"Performance and complications of lumbar puncture in memory clinics: results of the multicenter lumbar puncture feasibility study","volume":"12","author":"Duits","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s13311-023-01370-8_bib84","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.parkreldis.2018.12.025","article-title":"Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)","volume":"62","author":"Prakash","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-023-01370-8_bib85","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fnagi.2016.00296","article-title":"Research lumbar punctures among African Americans and Caucasians: perception predicts experience","volume":"8","author":"Howell","year":"2016","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"10.1007\/s13311-023-01370-8_bib86","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.wad.0000194014.43575.fd","article-title":"Safety and acceptability of the research lumbar puncture","volume":"19","author":"Peskind","year":"2005","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib87","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/alz.12372","article-title":"State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease","volume":"18","author":"Hampel","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"8","key":"10.1007\/s13311-023-01370-8_bib88","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1056\/NEJMoa1603265","article-title":"Assessing the risks associated with MRI in patients with a pacemaker or defibrillator","volume":"376","author":"Russo","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib89","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.hrthm.2017.10.022","article-title":"Safety of magnetic resonance imaging in patients with legacy pacemakers and defibrillators and abandoned leads","volume":"15","author":"Padmanabhan","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1007\/s13311-023-01370-8_bib90","article-title":"3 Tesla magnetic resonance imaging in patients with cardiac implantable electronic devices: a single centre experience","author":"Fluschnik","year":"2022","journal-title":"Europace"},{"issue":"Suppl 1","key":"10.1007\/s13311-023-01370-8_bib91","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00117-019-0541-6","article-title":"MR safety assessment of active implantable medical devices","volume":"59","author":"Aissani","year":"2019","journal-title":"Radiologe"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib92","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00234-010-0737-y","article-title":"Clinical safety of magnetic resonance imaging in patients with implanted SynchroMed EL infusion pumps","volume":"53","author":"Diehn","year":"2011","journal-title":"Neuroradiology"},{"issue":"5","key":"10.1007\/s13311-023-01370-8_bib93","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1213\/ANE.0b013e318210d017","article-title":"The safety of magnetic resonance imaging in patients with programmable implanted intrathecal drug delivery systems: a 3-year prospective study","volume":"112","author":"De Andres","year":"2011","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32289-x","article-title":"A Pilot randomized trial to examine effects of a hybrid closed-loop insulin delivery system on neurodevelopmental and cognitive outcomes in adolescents with type 1 diabetes","volume":"13","author":"Reiss","year":"2022","journal-title":"Nat Commun"},{"issue":"12","key":"10.1007\/s13311-023-01370-8_bib95","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.37288","article-title":"Clinician trends in prescribing direct oral anticoagulants for US Medicare beneficiaries","volume":"4","author":"Wheelock","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib96","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s12872-021-02295-w","article-title":"Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends","volume":"21","author":"Shiyovich","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1007\/s13311-023-01370-8_bib97","series-title":"A brain scan may predict Alzheimer's. Should you get one?","author":"Span","year":"2019"},{"key":"10.1007\/s13311-023-01370-8_bib98","article-title":"Florbetaben PET in the early diagnosis of Alzheimer's disease: a discrete event simulation to explore its potential value and key data gaps","volume":"2012","author":"Guo","year":"2012","journal-title":"Int J Alzheimers Dis"},{"issue":"4","key":"10.1007\/s13311-023-01370-8_bib99","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/03007995.2016.1277197","article-title":"Clinical and cost implications of amyloid beta detection with amyloid beta positron emission tomography imaging in early Alzheimer's disease - the case of florbetapir","volume":"33","author":"Hornberger","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib100","first-page":"63","article-title":"Cost-effectiveness of florbetapir-PET in Alzheimer's disease: a Spanish societal perspective","volume":"18","author":"Hornberger","year":"2015","journal-title":"J Ment Health Policy Econ"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib101","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12962-021-00300-9","article-title":"Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment","volume":"19","author":"Lee","year":"2021","journal-title":"Cost Eff Resour Alloc"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib102","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib103","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib104","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13195-017-0315-1","article-title":"Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers","volume":"9","author":"Howell","year":"2017","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib105","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jamaneurol.2018.4249","article-title":"Assessment of racial disparities in biomarkers for Alzheimer disease","volume":"76","author":"Morris","year":"2019","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib106","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.25543","article-title":"Interleukin 9 alterations linked to alzheimer disease in african americans","volume":"86","author":"Wharton","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-023-01370-8_bib107","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40035-020-0186-4","article-title":"Race modifies default mode connectivity in Alzheimer's disease","volume":"9","author":"Misiura","year":"2020","journal-title":"Transl Neurodegener"},{"issue":"9","key":"10.1007\/s13311-023-01370-8_bib108","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/15265161.2010.492888","article-title":"Racial, ethnic, and tribal classifications in biomedical research with biological and group harm","volume":"10","author":"McGregor","year":"2010","journal-title":"Am J Bioeth"},{"key":"10.1007\/s13311-023-01370-8_bib109","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6939-12-16","article-title":"Secondary uses and the governance of de-identified data: lessons from the human genome diversity panel","volume":"12","author":"Fullerton","year":"2011","journal-title":"BMC Med Ethics"},{"issue":"5","key":"10.1007\/s13311-023-01370-8_bib110","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ajhg.2018.10.011","article-title":"ASHG denounces attempts to link genetics and racial supremacy","volume":"103","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib111","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/alz.12377","article-title":"Tau pathologies mediate the association of blood pressure with cognitive impairment in adults without dementia: the CABLE study","volume":"18","author":"Hu","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib112","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13195-021-00822-7","article-title":"Associations of healthy lifestyles with cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact older adults: the CABLE study","volume":"13","author":"Hou","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"17","key":"10.1007\/s13311-023-01370-8_bib113","doi-asserted-by":"crossref","first-page":"e2378","DOI":"10.1212\/WNL.0000000000010629","article-title":"Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE epsilon4 genotype","volume":"95","author":"Babapour Mofrad","year":"2020","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01370-8_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104241","article-title":"Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS)","volume":"83","author":"Saunders","year":"2022","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1007\/s13311-023-01370-8_bib115","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/alz.12609","article-title":"Reporting and social construction of race in Alzheimer's disease clinical trials","volume":"18","author":"Hu","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1007\/s13311-023-01370-8_bib116","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/gim.2016.183","article-title":"The Precision Medicine Initiative's All of Us Research Program: an agenda for research on its ethical, legal, and social issues","volume":"19","author":"Sankar","year":"2017","journal-title":"Genet Med"},{"key":"10.1007\/s13311-023-01370-8_bib117","author":"Corporation R"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib118","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1258\/135581902760082517","article-title":"What does \u2018access to health care' mean?","volume":"7","author":"Gulliford","year":"2002","journal-title":"J Health Serv Res Policy"},{"key":"10.1007\/s13311-023-01370-8_bib119","author":"Quality AfHRa"},{"issue":"5","key":"10.1007\/s13311-023-01370-8_bib120","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/alz.12470","article-title":"Expected wait times for access to a disease-modifying Alzheimer's treatment in the United States","volume":"18","author":"Mattke","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"9","key":"10.1007\/s13311-023-01370-8_bib121","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","article-title":"Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"56","author":"Knopman","year":"2001","journal-title":"Neurology"},{"issue":"11","key":"10.1007\/s13311-023-01370-8_bib122","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2188\/jea.JE20200602","article-title":"Rural-urban disparities in the prevalence of mild cognitive impairment and dementia in Taiwan: a door-to-door nationwide study","volume":"32","author":"Liu","year":"2022","journal-title":"J Epidemiol"},{"issue":"11","key":"10.1007\/s13311-023-01370-8_bib123","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052704","article-title":"Prevalence of Alzheimer's disease in rural and urban areas in Cuba and factors influencing on its occurrence: epidemiological cross-sectional protocol","volume":"12","author":"Lopez Ricardo","year":"2022","journal-title":"BMJ Open"},{"issue":"7","key":"10.1007\/s13311-023-01370-8_bib124","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/alz.12285","article-title":"Rural-urban differences in diagnostic incidence and prevalence of Alzheimer's disease and related dementias","volume":"17","author":"Rahman","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib125","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jrh.12155","article-title":"Rural-urban differences in Alzheimer's disease and related disorders diagnostic prevalence in Kentucky and West Virginia","volume":"32","author":"Abner","year":"2016","journal-title":"J Rural Health"},{"issue":"8","key":"10.1007\/s13311-023-01370-8_bib126","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.25805","article-title":"Rural-urban disparities in diagnosis of early-onset dementia","volume":"5","author":"Xu","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1007\/s13311-023-01370-8_bib127","article-title":"Rural health disparities in health care utilization for dementia in Minnesota","author":"Rhew","year":"2022","journal-title":"J Rural Health"},{"issue":"12","key":"10.1007\/s13311-023-01370-8_bib128","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1377\/hlthaff.2019.00918","article-title":"Access, quality, and financial performance of rural hospitals following health system affiliation","volume":"38","author":"O'Hanlon","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"9","key":"10.1007\/s13311-023-01370-8_bib129","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jacr.2014.02.013","article-title":"The scope and distribution of imaging services at critical access hospitals","volume":"11","author":"Khaliq","year":"2014","journal-title":"J Am Coll Radiol"},{"key":"10.1007\/s13311-023-01370-8_bib130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2018.08.004","article-title":"Where there is no brain imaging: safety and diagnostic value of lumbar puncture in patients with neurological disorders in a rural hospital of Central Africa","volume":"393","author":"Mukendi","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-023-01370-8_bib131","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbi.2020.12.021","article-title":"Sex-specific associations between cerebrospinal fluid inflammatory marker levels and cognitive function in antiretroviral treated people living with HIV in rural Uganda","volume":"93","author":"Vecchio","year":"2021","journal-title":"Brain Behav Immun"},{"issue":"9","key":"10.1007\/s13311-023-01370-8_bib132","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.clineuro.2013.04.008","article-title":"Clinical presentation, etiology, and survival in adult acute encephalitis syndrome in rural Central India","volume":"115","author":"Joshi","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib133","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4269\/ajtmh.18-0434","article-title":"Etiology of central nervous system infections in a rural area of Nepal using molecular approaches","volume":"101","author":"Sall","year":"2019","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1007\/s13311-023-01370-8_bib134","article-title":"Comparison of rates of emergency department procedures and critical diagnoses in metropolitan and rural hospitals","volume":"15","author":"Waymack","year":"2015","journal-title":"Rural Remote Health"},{"key":"10.1007\/s13311-023-01370-8_bib135","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clineuro.2015.12.021","article-title":"Cost-effectiveness analysis of CTA and LP for evaluation of suspected SAH after negative non-contrast CT","volume":"142","author":"Wu","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib136","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/1087057103252618","article-title":"The effect of freeze\/thaw cycles on the stability of compounds in DMSO","volume":"8","author":"Kozikowski","year":"2003","journal-title":"J Biomol Screen"},{"issue":"7","key":"10.1007\/s13311-023-01370-8_bib137","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0003-9969(00)00026-1","article-title":"Precipitation of specific proteins by freeze-thawing of human saliva","volume":"45","author":"Francis","year":"2000","journal-title":"Arch Oral Biol"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib138","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11033-019-05176-w","article-title":"A simplified quick microbial genomic DNA extraction via freeze-thawing cycles","volume":"47","author":"Chen","year":"2020","journal-title":"Mol Biol Rep"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib139","first-page":"81","article-title":"A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid","volume":"9","author":"Falk","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1007\/s13311-023-01370-8_bib140","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1373\/clinchem.2008.120717","article-title":"Measurement and quality control issues in multiplex protein assays: a case study","volume":"55","author":"Ellington","year":"2009","journal-title":"Clin Chem"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib141","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1373\/clinchem.2004.039735","article-title":"Effects of processing and storage conditions on amyloid beta (1\u201342) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice","volume":"51","author":"Schoonenboom","year":"2005","journal-title":"Clin Chem"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib142","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ana.22244","article-title":"Eating and hypothalamus changes in behavioral-variant frontotemporal dementia","volume":"69","author":"Piguet","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-023-01370-8_bib143","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fimmu.2019.00480","article-title":"CSF cytokines in aging, multiple sclerosis, and dementia","volume":"10","author":"Hu","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib144","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24220-7","article-title":"Alzheimer's disease neuroimaging I. Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer's disease","volume":"12","author":"Hu","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/acn3.50956","article-title":"High-resolution metabolomic profiling of Alzheimer's disease in plasma","volume":"7","author":"Niedzwiecki","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"10.1007\/s13311-023-01370-8_bib146","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1515\/cclm-2013-0800","article-title":"Instability of cerebrospinal fluid after delayed storage and repeated freezing: a holistic study by drop coating deposition Raman spectroscopy","volume":"52","author":"Klener","year":"2014","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"10.1007\/s13311-023-01370-8_bib147","doi-asserted-by":"crossref","DOI":"10.4155\/bio.15.57","article-title":"When close is not close enough: a comparison of endogenous and recombinant biomarker stability samples","volume":"7","author":"Fraser","year":"2015","journal-title":"Bioanalysis"},{"issue":"8","key":"10.1007\/s13311-023-01370-8_bib148","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/alz.12510","article-title":"Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group","volume":"18","author":"Verberk","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib149","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3233\/JAD-160865","article-title":"Cerebrospinal fluid Abeta42\/Abeta40 as a means to limiting tube- and storage-dependent pre-analytical variability in clinical setting","volume":"57","author":"Gervaise-Henry","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib150","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000506278","article-title":"Stability of plasma amyloid-beta 1\u201340, amyloid-beta 1\u201342, and total tau protein over repeated freeze\/thaw cycles","volume":"10","author":"Liu","year":"2020","journal-title":"Dement Geriatr Cogn Dis Extra"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib151","article-title":"Effects of pre-analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration","volume":"13","author":"Ashton","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1007\/s13311-023-01370-8_bib152","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.dadm.2018.06.001","article-title":"Stability of blood-based biomarkers of Alzheimer's disease over multiple freeze-thaw cycles","volume":"10","author":"Keshavan","year":"2018","journal-title":"Alzheimers Dement (Amst)"},{"issue":"6608","key":"10.1007\/s13311-023-01370-8_bib153","doi-asserted-by":"crossref","DOI":"10.1126\/science.abk0637","article-title":"GPNMB confers risk for Parkinson's disease through interaction with alpha-synuclein","volume":"377","author":"Diaz-Ortiz","year":"2022","journal-title":"Science"},{"key":"10.1007\/s13311-023-01370-8_bib154","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.638718","article-title":"Preanalytical stability of CSF total and oligomeric alpha-synuclein","volume":"13","author":"Abdi","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06445","article-title":"Comparison of multiplex cytokine assays in a pediatric cohort with epilepsy","volume":"7","author":"Numis","year":"2021","journal-title":"Heliyon"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib156","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/aje\/kwab251","article-title":"Stability of serum bone-mineral, kidney, and cardiac biomarkers after a freeze-thaw cycle: the ARIC study","volume":"191","author":"Ishigami","year":"2022","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1007\/s13311-023-01370-8_bib157","doi-asserted-by":"crossref","DOI":"10.3390\/metabo9100236","article-title":"Assessing the pre-analytical stability of small-molecule metabolites in cerebrospinal fluid using direct-infusion metabolomics","volume":"9","author":"Haijes","year":"2019","journal-title":"Metabolites"},{"issue":"6","key":"10.1007\/s13311-023-01370-8_bib158","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4155\/bio-2019-0303","article-title":"A novel, robust method for quantification of multiple kynurenine pathway metabolites in the cerebrospinal fluid","volume":"12","author":"Schwieler","year":"2020","journal-title":"Bioanalysis"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib159","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/acn3.160","article-title":"CSF beta-amyloid 1\u201342 - what are we measuring in Alzheimer's disease?","volume":"2","author":"Hu","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib160","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-45976-5","article-title":"Associations between serum and plasma brain-derived neurotrophic factor and influence of storage time and centrifugation strategy","volume":"9","author":"Gejl","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib161","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77046-6","article-title":"Factors affecting stability of plasma brain-derived neurotrophic factor","volume":"10","author":"Wessels","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib162","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s13365-020-00836-1","article-title":"Beta-amyloid (Abeta) uptake by PET imaging in older HIV+ and HIV- individuals","volume":"26","author":"Mohamed","year":"2020","journal-title":"J Neurovirol"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib163","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12883-021-02468-2","article-title":"Low cerebrospinal fluid amyloid-betaeta 1\u201342 in patients with tuberculous meningitis","volume":"21","author":"Stroffolini","year":"2021","journal-title":"BMC Neurol"},{"key":"10.1007\/s13311-023-01370-8_bib164","first-page":"1","article-title":"CSF IL-8 associated with response to gene therapy in a case series of spinal muscular atrophy","author":"Verma","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1007\/s13311-023-01370-8_bib165","doi-asserted-by":"crossref","first-page":"e718","DOI":"10.1212\/WNL.0000000000008677","article-title":"Proteinopathy and longitudinal changes in functional connectivity networks in Parkinson disease","volume":"94","author":"Campbell","year":"2020","journal-title":"Neurology"},{"issue":"24","key":"10.1007\/s13311-023-01370-8_bib166","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1212\/WNL.0000000000001681","article-title":"CSF proteins and resting-state functional connectivity in Parkinson disease","volume":"84","author":"Campbell","year":"2015","journal-title":"Neurology"},{"issue":"Pt 5","key":"10.1007\/s13311-023-01370-8_bib167","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/brain\/awq075","article-title":"Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease","volume":"133","author":"Zhou","year":"2010","journal-title":"Brain"},{"issue":"15","key":"10.1007\/s13311-023-01370-8_bib168","doi-asserted-by":"crossref","first-page":"e1640","DOI":"10.1212\/WNL.0000000000200953","article-title":"CSF Alzheimer disease biomarkers: time-varying relationships with MCI symptom onset and associations with age, sex, and ApoE4","volume":"99","author":"Greenberg","year":"2022","journal-title":"Neurology"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib169","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000051246","article-title":"Cerebrospinal fluid tau levels increase with age in healthy individuals","volume":"12","author":"Blomberg","year":"2001","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"6","key":"10.1007\/s13311-023-01370-8_bib170","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jalz.2019.01.015","article-title":"Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study","volume":"15","author":"Lleo","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib171","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191240","article-title":"The nonlinear relationship between cerebrospinal fluid Abeta42 and tau in preclinical Alzheimer's disease","volume":"13","author":"de Leon","year":"2018","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib172","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat Genet"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib173","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22491-8","article-title":"Common variants in Alzheimer's disease and risk stratification by polygenic risk scores","volume":"12","author":"de Rojas","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib174","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ana.26131","article-title":"Polygenic risk score for Alzheimer's disease in Caribbean Hispanics","volume":"90","author":"Sariya","year":"2021","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib175","article-title":"Genetic and polygenic risk score analysis for Alzheimer's disease in the Chinese population","volume":"12","author":"Zhou","year":"2020","journal-title":"Alzheimers Dement (Amst)"},{"issue":"4","key":"10.1007\/s13311-023-01370-8_bib176","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3233\/JAD-122317","article-title":"Validation of assays for measurement of amyloid-beta peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer's disease treated with solanezumab","volume":"34","author":"Lachno","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"10.1007\/s13311-023-01370-8_bib177","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1001\/archneurol.2012.90","article-title":"Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease","volume":"69","author":"Blennow","year":"2012","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1007\/s13311-023-01370-8_bib178","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jalz.2011.09.224","article-title":"Safety and biomarker effects of solanezumab in patients with Alzheimer's disease","volume":"8","author":"Farlow","year":"2012","journal-title":"Alzheimers Dement"},{"issue":"363","key":"10.1007\/s13311-023-01370-8_bib179","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9704","article-title":"The BACE1 inhibitor verubecestat (MK-8931) reduces CNS beta-amyloid in animal models and in Alzheimer's disease patients","volume":"8","author":"Kennedy","year":"2016","journal-title":"Sci Transl Med"},{"issue":"18","key":"10.1007\/s13311-023-01370-8_bib180","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer's disease","volume":"378","author":"Egan","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib181","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer's disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib182","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","article-title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Abeta protofibril antibody","volume":"13","author":"Swanson","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.1007\/s13311-023-01370-8_bib183","article-title":"Lecanemab in early Alzheimer's disease","author":"van Dyck","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-023-01370-8_bib184","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40478-016-0277-8","article-title":"CSF complement 3 and factor H are staging biomarkers in Alzheimer's disease","volume":"4","author":"Hu","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-023-01370-8_bib185","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.676744","article-title":"Temporal ordering of inflammatory analytes sTNFR2 and sTREM2 in relation to Alzheimer's disease biomarkers and clinical outcomes","volume":"13","author":"Pillai","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"10.1007\/s13311-023-01370-8_bib186","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1474-4422(22)00027-8","article-title":"Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study","volume":"21","author":"Morenas-Rodriguez","year":"2022","journal-title":"Lancet Neurol"},{"issue":"507","key":"10.1007\/s13311-023-01370-8_bib187","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav6221","article-title":"Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease","volume":"11","author":"Ewers","year":"2019","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1007\/s13311-023-01370-8_bib188","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809712","article-title":"CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline","volume":"10","author":"Suarez-Calvet","year":"2018","journal-title":"EMBO Mol Med"},{"issue":"9","key":"10.1007\/s13311-023-01370-8_bib189","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1212\/WNL.0b013e318266fa70","article-title":"Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease","volume":"79","author":"Hu","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib190","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.dadm.2015.06.008","article-title":"Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study","volume":"1","author":"Leung","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"issue":"9","key":"10.1007\/s13311-023-01370-8_bib191","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.biopsych.2013.11.032","article-title":"Phosphorylated tau-Abeta42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid","volume":"75","author":"Harari","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib192","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13024-022-00521-3","article-title":"Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease","volume":"17","author":"Visser","year":"2022","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-023-01370-8_bib193","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.exger.2017.01.025","article-title":"CSF protein changes associated with hippocampal sclerosis risk gene variants highlight impact of GRN\/PGRN","volume":"90","author":"Fardo","year":"2017","journal-title":"Exp Gerontol"},{"issue":"7","key":"10.1007\/s13311-023-01370-8_bib194","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/acn3.50827","article-title":"Key inflammatory pathway activations in the MCI stage of Alzheimer's disease","volume":"6","author":"Pillai","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"10.1007\/s13311-023-01370-8_bib195","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00406-013-0405-4","article-title":"Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer's disease","volume":"263","author":"Guo","year":"2013","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"8","key":"10.1007\/s13311-023-01370-8_bib196","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134368","article-title":"A subset of cerebrospinal fluid proteins from a multi-analyte panel associated with brain atrophy, disease classification and prediction in Alzheimer's disease","volume":"10","author":"Khan","year":"2015","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1007\/s13311-023-01370-8_bib197","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1038\/tp.2014.58","article-title":"Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals","volume":"4","author":"Paterson","year":"2014","journal-title":"Transl Psychiatry"},{"issue":"12","key":"10.1007\/s13311-023-01370-8_bib198","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1093\/brain\/awaa325","article-title":"Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics","volume":"143","author":"Tijms","year":"2020","journal-title":"Brain"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib199","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3233\/JAD-170887","article-title":"Bi-directional association of cerebrospinal fluid immune markers with stage of Alzheimer's disease pathogenesis","volume":"63","author":"Meyer","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"10.1007\/s13311-023-01370-8_bib200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004758","article-title":"Genome-wide association study of CSF levels of 59 Alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation","volume":"10","author":"Kauwe","year":"2014","journal-title":"PLoS Genet"},{"issue":"20","key":"10.1007\/s13311-023-01370-8_bib201","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1093\/hmg\/dds296","article-title":"Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease","volume":"21","author":"Cruchaga","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1007\/s13311-023-01370-8_bib202","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s11427-021-1984-5","article-title":"The association of cerebrospinal fluid pressure with optic nerve head and macular vessel density","volume":"65","author":"Liu","year":"2022","journal-title":"Sci China Life Sci"},{"issue":"208","key":"10.1007\/s13311-023-01370-8_bib203","first-page":"e1","article-title":"A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin","volume":"37","author":"Deming","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-023-01370-8_bib204","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7760","article-title":"Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE","volume":"6","author":"Ayton","year":"2015","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-023-01370-8_bib205","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.nbd.2018.12.010","article-title":"Cerebrospinal fluid ferritin levels predict brain hypometabolism in people with underlying beta-amyloid pathology","volume":"124","author":"Diouf","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib206","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3233\/JAD-220002","article-title":"The associations of cerebrospinal fluid ferritin with neurodegeneration and neuroinflammation along the Alzheimer's disease continuum","volume":"88","author":"Pan","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1007\/s13311-023-01370-8_bib207","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/mp.2016.206","article-title":"Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway","volume":"22","author":"Varma","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1007\/s13311-023-01370-8_bib208","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.638922","article-title":"TNFRSF1B gene variants and related soluble TNFR2 levels impact resilience in Alzheimer's disease","volume":"13","author":"Pillai","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib209","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3233\/JAD-190314","article-title":"Subtypes based on six apolipoproteins in non-demented elderly are associated with cognitive decline and subsequent tau accumulation in cerebrospinal fluid","volume":"72","author":"Zou","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-023-01370-8_bib210","article-title":"The mediating role of inflammation in the relationship between alpha-synuclein and cognitive functioning","author":"Dabiri","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1007\/s13311-023-01370-8_bib211","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neurobiolaging.2021.04.025","article-title":"Regional relationships between CSF VEGF levels and Alzheimer's disease brain biomarkers and cognition","volume":"105","author":"Tubi","year":"2021","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10.1007\/s13311-023-01370-8_bib212","volume":"29","author":"Cadamuro","year":"2019","journal-title":"Biochem Med (Zagreb)"},{"issue":"Pt B","key":"10.1007\/s13311-023-01370-8_bib213","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cca.2015.10.010","article-title":"Pre-analytical phase: the automated ProTube device supports quality assurance in the phlebotomy process","volume":"451","author":"Piva","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1007\/s13311-023-01370-8_bib214","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fnagi.2018.00253","article-title":"Automation vs. experience: measuring Alzheimer's beta-amyloid 1\u201342 peptide in the CSF","volume":"10","author":"Kollhoff","year":"2018","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"10.1007\/s13311-023-01370-8_bib215","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00401-013-1197-3","article-title":"Alzheimer's disease biomarkers: walk with deliberate haste, don't run blithely on?","volume":"126","author":"Hu","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"7","key":"10.1007\/s13311-023-01370-8_bib216","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/acn3.51109","article-title":"Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer's disease","volume":"7","author":"Pillai","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"10.1007\/s13311-023-01370-8_bib217","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/proteomes9030036","article-title":"CSF proteomic Alzheimer's disease-predictive subtypes in cognitively intact amyloid negative individuals","volume":"9","author":"Tijms","year":"2021","journal-title":"Proteomes"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01370-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-023-01370-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923019062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923019062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01370-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:16:01Z","timestamp":1761808561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923019062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":217,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1878747923019062"],"URL":"https:\/\/doi.org\/10.1007\/s13311-023-01370-8","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Charting the Next Road Map for CSF Biomarkers in Alzheimer's Disease and Related Dementias","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-023-01370-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}